Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1973 Jun;36(3):350–353. doi: 10.1136/jnnp.36.3.350

Levodopa therapy for Parkinsonism in the Shy-Drager syndrome

M J Aminoff 1,1, C S Wilcox 1, M M Woakes 1, M Kremer 1
PMCID: PMC494332  PMID: 4714096

Abstract

The results of levodopa treatment in five patients with Parkinsonism of the Shy-Drager syndrome are reported. There was no improvement in the neurological signs or functional disability in any patient. Mean values for lying and standing blood pressure increased significantly in three of the five patients during treatment, and were unchanged in the other two patients. The significance of these results is discussed. It is concluded that levodopa is not of therapeutic value in patients with this disorder.

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDEN N. E., DAHLSTROEM A., FUXE K., LARSSON K. FURTHER EVIDENCE FOR THE PRESENCE OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS IN THE RAT. Am J Anat. 1965 Jan;116:329–333. doi: 10.1002/aja.1001160117. [DOI] [PubMed] [Google Scholar]
  2. Aminoff M. J., Wilcox C. S. Assessment of autonomic function in patients with a Parkinsonian syndrome. Br Med J. 1971 Oct 9;4(5779):80–84. doi: 10.1136/bmj.4.5779.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BARBEAU A. The pathogenesis of Parkinson's disease: a new hypothesis. Can Med Assoc J. 1962 Oct 13;87:802–807. [PMC free article] [PubMed] [Google Scholar]
  4. Calne D. B., Brennan J., Spiers A. S., Stern G. M. Hypotension caused by L-dopa. Br Med J. 1970 Feb 21;1(5694):474–475. doi: 10.1136/bmj.1.5694.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Calne D. B., Stern G. M., Laurence D. R., Sharkey J., Armitage P. L-dopa in postencephalitic parkinsonism. Lancet. 1969 Apr 12;1(7598):744–746. doi: 10.1016/s0140-6736(69)91751-6. [DOI] [PubMed] [Google Scholar]
  6. Cotzias G. C., Papavasiliou P. S., Gellene R. Modification of Parkinsonism--chronic treatment with L-dopa. N Engl J Med. 1969 Feb 13;280(7):337–345. doi: 10.1056/NEJM196902132800701. [DOI] [PubMed] [Google Scholar]
  7. Galindo A., Krnjević K., Schwartz S. Micro-iontophoretic studies on neurones in the cuneate nucleus. J Physiol. 1967 Sep;192(2):359–377. doi: 10.1113/jphysiol.1967.sp008305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Godwin-Austen R. B., Tomlinson E. B., Frears C. C., Kok H. W. Effects of L-dopa in Parkinson's disease. Lancet. 1969 Jul 26;2(7613):165–168. doi: 10.1016/s0140-6736(69)91417-2. [DOI] [PubMed] [Google Scholar]
  9. Henning M., Rubenson A. Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat. J Pharm Pharmacol. 1970 Aug;22(8):553–560. doi: 10.1111/j.2042-7158.1970.tb10570.x. [DOI] [PubMed] [Google Scholar]
  10. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev. 1966 Jun;18(2):925–964. [PubMed] [Google Scholar]
  11. Izumi K., Inoue N., Shirabe T., Miyazaki T., Kuroiwa Y. Failed levodopa therapy in striato-nigral degeneration. Lancet. 1971 Jun 26;1(7713):1355–1355. doi: 10.1016/s0140-6736(71)91914-3. [DOI] [PubMed] [Google Scholar]
  12. Johnson R. H., Lee G. de J., Oppenheimer D. R., Spalding J. M. Autonomic failure with orthostatic hypotension due to intermediolateral column degeneration. A report of two cases with autopsies. Q J Med. 1966 Apr;35(138):276–292. [PubMed] [Google Scholar]
  13. Klawans H. L., Jr, Zeitlin E. L-dopa in Parkinsonism associated with cerebellar dysfunction (probable olivopontocerebellar degeneration). J Neurol Neurosurg Psychiatry. 1971 Feb;34(1):14–19. doi: 10.1136/jnnp.34.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Klawans H., Jr, Ilahi M. M., Shenker D. Theoretical implications of the use of L-dopa in parkinsonism. A review. Acta Neurol Scand. 1970;46(4):409–441. doi: 10.1111/j.1600-0404.1970.tb05804.x. [DOI] [PubMed] [Google Scholar]
  15. MCGEER P. L., BOULDING J. E., GIBSON W. C., FOULKES R. G. Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine. JAMA. 1961 Sep 9;177:665–670. doi: 10.1001/jama.1961.03040360001001. [DOI] [PubMed] [Google Scholar]
  16. McLennan H., York D. H. The action of dopamine on neurones of the caudate nucleus. J Physiol. 1967 Apr;189(3):393–402. doi: 10.1113/jphysiol.1967.sp008175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mena I., Court J., Fuenzalida S., Papavasiliou P. S., Cotzias G. C. Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophane. N Engl J Med. 1970 Jan 1;282(1):5–10. doi: 10.1056/NEJM197001012820102. [DOI] [PubMed] [Google Scholar]
  18. Nick J., Contamin F., Escourolle R., Guillard A., Marcantoni J. P. Hypotension orthostatique idiopathique avec syndrome neurologique complexe à prédominance extra-pyramidale. Etude anatomo-clinique d'un cas. Rev Neurol (Paris) 1967 Mar;116(3):213–227. [PubMed] [Google Scholar]
  19. POIRIER L. J., SOURKES T. L. INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM. Brain. 1965 Mar;88:181–192. doi: 10.1093/brain/88.1.181. [DOI] [PubMed] [Google Scholar]
  20. SHY G. M., DRAGER G. A. A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study. Arch Neurol. 1960 May;2:511–527. doi: 10.1001/archneur.1960.03840110025004. [DOI] [PubMed] [Google Scholar]
  21. Schwarz G. A. The orthostatic hypotension syndrome of Shy-Drager. A clinicopathologic report. Arch Neurol. 1967 Feb;16(2):123–139. doi: 10.1001/archneur.1967.00470200011002. [DOI] [PubMed] [Google Scholar]
  22. Thomas J. E., Schirger A. Idiopathic orthostatic hypotension; a study of its natural history in 57 neurologically affected patients. Arch Neurol. 1970 Apr;22(4):289–293. doi: 10.1001/archneur.1970.00480220003001. [DOI] [PubMed] [Google Scholar]
  23. Watanabe A. M., Chase T. N., Cardon P. V. Effect of L-dopa alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexes. Clin Pharmacol Ther. 1970 Sep-Oct;11(5):740–746. doi: 10.1002/cpt1970115740. [DOI] [PubMed] [Google Scholar]
  24. Yahr M. D., Duvoisin R. C., Hoehn M. M., Schear M. J., Barrett R. E. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism. Trans Am Neurol Assoc. 1968;93:56–63. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES